Tolvaptan Treatment to Reverse Worsening Outpatient Heart Failure: Possible Role of Copeptin In Identifying Responders (TROUPER)
Phase of Trial: Phase IV
Latest Information Update: 17 Nov 2017
At a glance
- Drugs Tolvaptan (Primary)
- Indications Cardiac oedema; Dyspnoea; Heart failure
- Focus Therapeutic Use
- Acronyms TROUPER
- 10 Nov 2017 Planned End Date changed from 1 Dec 2017 to 1 Jul 2018.
- 10 Nov 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Mar 2018.
- 10 Jun 2017 Biomarkers information updated